Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 9071568)

Published in Genes Chromosomes Cancer on March 01, 1997

Authors

M Lastowska1, E Nacheva, A McGuckin, A Curtis, C Grace, A Pearson, N Bown

Author Affiliations

1: Department of Human Genetics, University of Newcastle upon Tyne, UK.

Articles by these authors

A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 6.12

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69

Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15

Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94

Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery (1990) 2.91

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88

The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J (1988) 2.81

Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51

Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36

Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene (2010) 2.11

African trypanosomiasis in two travelers from the United States. Clin Infect Dis (1999) 2.08

The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem Sci (1994) 1.93

Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92

Sexually transmitted diseases in sexually abused children. Pediatrics (1983) 1.92

Predictive testing for Huntington's disease with linked DNA markers. Lancet (1989) 1.90

The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. J Diarrhoeal Dis Res (1984) 1.84

Rapid detection of single base mismatches as heteroduplexes on Hydrolink gels. Trends Genet (1991) 1.83

A high molecular weight precursor of luteinizing hormone releasing hormone from rat hypothalamus. Endocrinology (1983) 1.81

Prenatal exclusion testing for Huntington's disease: a problem of too much information. J Med Genet (1989) 1.70

Evaluation of the impact of allogenic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years. The Northern Regional Haematology Group. Leukemia (1995) 1.68

Staff in Australian nursing homes: their qualifications, experience and attitudes. Contemp Nurse (1993) 1.67

Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet (1999) 1.67

Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem (1993) 1.65

EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc (2000) 1.64

Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet (2004) 1.63

Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry (2010) 1.60

Anoxygenic photosynthesis modulated Proterozoic oxygen and sustained Earth's middle age. Proc Natl Acad Sci U S A (2009) 1.58

Guidance and activation of murine macrophages by nanometric scale topography. Exp Cell Res (1996) 1.56

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55

Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res (2001) 1.52

Drosophila scavenger receptor CI is a pattern recognition receptor for bacteria. Immunity (2001) 1.52

Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ (2004) 1.51

Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis. Hum Genet (1988) 1.47

A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood (1988) 1.44

A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations. Blood (1990) 1.43

Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer (2001) 1.43

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol (1998) 1.41

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood (2001) 1.40

Genetic differences between cystic fibrosis with and without meconium ileus. Lancet (1989) 1.40

Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill (2008) 1.39

Options for prenatal testing for Huntington's disease using linked DNA probes. J Med Genet (1990) 1.39

Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood (1996) 1.34

Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations. Leukemia (2005) 1.31

Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes: assignment of the human thymocyte CD1 antigen genes to chromosome 1. EMBO J (1988) 1.26

Racial identity and self-esteem: problems peculiar to biracial children. J Am Acad Child Psychiatry (1985) 1.25

Neuroferritinopathy in a French family with late onset dominant dystonia. J Med Genet (2003) 1.24

Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro Surveill (2007) 1.24

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol (2001) 1.23

Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J Biol Chem (1999) 1.23

Synergistic and hierarchical adhesive and topographic guidance of BHK cells. Exp Cell Res (1996) 1.20

Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet (1994) 1.20

Failure of vaccination to prevent outbreaks of foot-and-mouth disease. Epidemiol Infect (1996) 1.20

Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities. Gastroenterology (1988) 1.19

A submicroscopic translocation, t(4;10), responsible for recurrent Wolf-Hirschhorn syndrome identified by allele loss and fluorescent in situ hybridisation. J Med Genet (1992) 1.18

Activation of macrophage-like cells by multiple grooved substrata. Topographical control of cell behaviour. Cell Biol Int (1995) 1.18

Conduct of phase I trials in children with cancer. J Clin Oncol (1998) 1.16

Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection. Health Technol Assess (2011) 1.13

Impaired recognition of disgust in Huntington's disease gene carriers. Brain (1997) 1.13

New thoughts on managing obesity. Gut (2004) 1.13

Atenolol disposition in young and elderly subjects. Br J Clin Pharmacol (1982) 1.13

Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens. J Clin Pathol (1992) 1.11

Towards a duty of care for biodiversity. Environ Manage (2010) 1.10

Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma. Genes Chromosomes Cancer (2001) 1.10

Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood (1994) 1.10

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer (2001) 1.10

Prenatal exclusion testing for Huntington disease using the polymerase chain reaction. Am J Med Genet (1989) 1.09

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09

Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Leukemia (1997) 1.09

Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. J Hosp Infect (2011) 1.08

Emergency department contact prior to suicide in mental health patients. Emerg Med J (2010) 1.07

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med (1988) 1.07

The haplotype distribution of the delta F508 mutation in cystic fibrosis families in Scotland. Hum Genet (1990) 1.07

BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene (1994) 1.05

Respondents' attitudes regarding participation in an epidemiologic study. Am J Epidemiol (1986) 1.05

A polycyclic terpenoid that alleviates oxidative stress. Proc Natl Acad Sci U S A (2008) 1.05

Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression. Genes Chromosomes Cancer (2007) 1.04

Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport (1998) 1.02

A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem (2000) 1.01

A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet (1993) 1.00

De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Northern Region Haematology Group. Leukemia (1995) 1.00

Pressure ulcer prophylaxis in elderly patients using polyurethane foam or Jay wheelchair cushions. Int J Rehabil Res (1994) 0.99

Analysis of GLRA1 in hereditary and sporadic hyperekplexia: a novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis. J Med Genet (1996) 0.98

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer (1997) 0.98

Gain of 1q is a marker of poor prognosis in Wilms' tumors. Genes Chromosomes Cancer (2013) 0.97

A systematic review of oral health assessment by nurses and carers for residents with dementia in residential care facilities. Spec Care Dentist (2006) 0.96

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96

Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood (1995) 0.96

Erythroleukaemia in the north of England: a population based study. J Clin Pathol (2001) 0.95

Antibiotic resistance: location, location, location. Clin Microbiol Infect (2007) 0.95

Hernia of the lung: a case report and review of literature. Conn Med (1997) 0.94

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol (2001) 0.94

Chromosome translocation in extraskeletal Ewing's tumour. Lancet (1984) 0.94

Flow cytometric enumeration of micronucleated reticulocytes: high transferability among 14 laboratories. Environ Mol Mutagen (2001) 0.94

Assessment of the behaviour and welfare of laying hens on free-range units. Vet Rec (2007) 0.92